These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18186849

  • 1. Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient.
    Anavekar NS, Chong AH, Norris R, Dowling J, Goodman D.
    Australas J Dermatol; 2008 Feb; 49(1):44-7. PubMed ID: 18186849
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T, Chan JJ.
    Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
    [Abstract] [Full Text] [Related]

  • 3. Progressive arm and leg stiffness in a patient with chronic renal impairment.
    Shin K, Granter SR, Coblyn JS, Gupta S.
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):557-62. PubMed ID: 18711420
    [Abstract] [Full Text] [Related]

  • 4. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
    Grobner T, Prischl FC.
    Semin Dial; 2008 Oct; 21(2):135-9. PubMed ID: 18226001
    [Abstract] [Full Text] [Related]

  • 5. [Nephrogenic systemic fibrosis: more hard times for renal failure patients].
    Plamondon I, Samson C, Watters AK, Bégin LR, Côté J, Déziel C, Quérin S.
    Nephrol Ther; 2007 Jul; 3(4):152-6. PubMed ID: 17658442
    [Abstract] [Full Text] [Related]

  • 6. Successful pregnancy in a hemodialysis patient and marked resolution of her nephrogenic systemic fibrosis.
    Khurana A, Nickel AE, Greene JF, Narayanan M, High WA, Foulks CJ.
    Am J Kidney Dis; 2008 Jun; 51(6):e29-32. PubMed ID: 18501778
    [Abstract] [Full Text] [Related]

  • 7. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D, Johnsen H, Juelsrud A, Løvhaug D.
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [Abstract] [Full Text] [Related]

  • 8. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
    van der Meij N, Keur I, van Lienden KP, Scheepstra CG, Bos JD.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2898-903. PubMed ID: 18257437
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis.
    Gilliet M, Cozzio A, Burg G, Nestle FO.
    Br J Dermatol; 2005 Mar 29; 152(3):531-6. PubMed ID: 15787823
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun 29; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 11. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Weiss AS, Lucia MS, Teitelbaum I.
    Nat Clin Pract Nephrol; 2007 Feb 29; 3(2):111-5. PubMed ID: 17251999
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 29; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 13. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.
    Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD.
    J Pathol; 2008 Apr 29; 214(5):584-93. PubMed ID: 18220317
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic fibrosing dermopathy.
    Firoz BF, Hunzeker CM, Soldano AC, Franks AG.
    Dermatol Online J; 2008 May 15; 14(5):11. PubMed ID: 18627747
    [Abstract] [Full Text] [Related]

  • 15. [Nephrogenic systemic fibrosis].
    Artunc F, Schanz S, Metze D, Heyne N.
    Dtsch Med Wochenschr; 2008 May 15; 133 Suppl():F1. PubMed ID: 18802876
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P, Skov L.
    Radiol Clin North Am; 2009 Sep 15; 47(5):833-40, vi. PubMed ID: 19744598
    [Abstract] [Full Text] [Related]

  • 17. UV-A1 therapy for nephrogenic systemic fibrosis.
    Tran KT, Prather HB, Cockerell CJ, Jacobe H.
    Arch Dermatol; 2009 Oct 15; 145(10):1170-4. PubMed ID: 19841406
    [Abstract] [Full Text] [Related]

  • 18. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.
    Panesar M, Banerjee S, Barone GW.
    Clin Transplant; 2008 Oct 15; 22(6):803-8. PubMed ID: 18713261
    [Abstract] [Full Text] [Related]

  • 19. New insights into nephrogenic systemic fibrosis.
    Swaminathan S, Shah SV.
    J Am Soc Nephrol; 2007 Oct 15; 18(10):2636-43. PubMed ID: 17855637
    [Abstract] [Full Text] [Related]

  • 20. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M, Davenport A, Clatworthy I, Lewin J, Deroide F, Hubbard V, Rustin MH.
    Br J Dermatol; 2008 Jun 15; 158(6):1358-62. PubMed ID: 18363754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.